Academic Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Brodkey, A. C.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Brodkey, A. C.
Related Collections
* Education, Psychiatrists
Academic Psychiatry 29:222-229, June 2005
© 2005 Academic Psychiatry


Perspective

The Role of the Pharmaceutical Industry in Teaching Psychopharmacology: A Growing Problem

Amy C. Brodkey, M.D.

Dr. Brodkey is Clinical Associate Professor of Psychiatry at the University of Pennsylvania Medical School, Philadelphia, Pennsylvania. Address correspondence to Dr. Brodkey, brodkeya{at}verizon.net (E-mail). Copyright © 2005 Academic Psychiatry.

OBJECTIVE: To describe and examine the role of the pharmaceutical industry in the teaching of psychopharmacology to residents and medical students and to make recommendations for changes in curriculum and policy based on these findings. METHODS: Literature reviews and discussions with experts, educators, and trainees. RESULTS: The pharmaceutical industry currently plays an extensive role in teaching psychopharmacology to trainees, both directly and indirectly. Attendance at industry-sponsored lectures and drug lunches, meetings with pharmaceutical representatives, and interactions involving the acceptance of various gifts are the most obvious venues. Less apparent but equally pervasive are the influence of industry-sponsored faculty and research and industry’s effect on the climate of practice and the profession as a whole. Replacing medical education with industry promotion in the guise of scholarship causes demonstrable harm to trainees, the public, and the profession. CONCLUSIONS: In light of these findings, the medical profession must reassert control of medical education and draw a firm barrier between commercial and professional pursuits. These issues must be actively, explicitly, and rigorously discussed with our colleagues and students.




This article has been cited by other articles:


Home page
Psychiatr. Serv.Home page
M. Sernyak and R. Rosenheck
Experience of VA Psychiatrists With Pharmaceutical Detailing of Antipsychotic Medications
Psychiatr Serv, October 1, 2007; 58(10): 1292 - 1296.
[Abstract] [Full Text] [PDF]


Home page
Acad. PsychiatryHome page
F. S. Sierles
The Association of Directors of Medical Student Education in Psychiatry
Acad Psychiatry, April 1, 2007; 31(2): 107 - 109.
[Full Text] [PDF]


Home page
Acad. PsychiatryHome page
C. M.A. Geppert
Medical Education and the Pharmaceutical Industry: A Review of Ethical Guidelines and Their Implications for Psychiatric Training
Acad Psychiatry, February 1, 2007; 31(1): 32 - 39.
[Abstract] [Full Text] [PDF]


Home page
Acad. PsychiatryHome page
M. J. Burke and A. C. Brodkey
Trends in Undergraduate Medical Education: Clinical Clerkship Learning Objectives
Acad Psychiatry, April 1, 2006; 30(2): 158 - 165.
[Abstract] [Full Text] [PDF]


Home page
Transcultural PsychiatryHome page
L. J. Kirmayer
Beyond the 'New Cross-cultural Psychiatry': Cultural Biology, Discursive Psychology and the Ironies of Globalization
Transcultural Psychiatry, March 1, 2006; 43(1): 126 - 144.
[Abstract] [PDF]


Home page
Acad. PsychiatryHome page
M. D. Jibson
Medical Education and the Pharmaceutical Industry: Managing an Uneasy Alliance
Acad Psychiatry, February 1, 2006; 30(1): 36 - 39.
[Full Text] [PDF]


Home page
JAMAHome page
F. S. Sierles, A. C. Brodkey, L. M. Cleary, F. A. McCurdy, M. Mintz, J. Frank, D. J. Lynn, J. Chao, B. Z. Morgenstern, W. Shore, et al.
Medical Students' Exposure to and Attitudes About Drug Company Interactions: A National Survey
JAMA, September 7, 2005; 294(9): 1034 - 1042.
[Abstract] [Full Text] [PDF]


Home page
Acad. PsychiatryHome page
M. D. Jibson
Psychopharmacology Training in Psychiatric Education: The Debate
Acad Psychiatry, June 1, 2005; 29(2): 120 - 123.
[Full Text] [PDF]


Home page
Acad. PsychiatryHome page
D. F. Klein
Comments on Psychiatric Education
Acad Psychiatry, June 1, 2005; 29(2): 128 - 133.
[Full Text] [PDF]


Home page
Acad. PsychiatryHome page
I. D. Glick and S. Zisook
The Challenge of Teaching Psychopharmacology in the New Millennium: The Role of Curricula
Acad Psychiatry, June 1, 2005; 29(2): 134 - 140.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2005 Academic Psychiatry. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Association of Chairs of Departments of Psychiatry American Association of Directors of Psychiatric Residency Training Association of Directors of Medical Student Education in Psychiatry Association for Academic Psychiatry
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org